Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
Human IL-1 beta, premium grade (Cat. No. ILB-H4110) stimulates proliferation of D10.G4.1 cells. The specific activity of Human IL-1 beta, premium grade is>5.00 x 10^7 IU/mg, which is calibrated against WHO International Standard INTERLEUKIN-1 BETA (IL-1ß, Human rDNA derived) (NIBSC code: 86/680) (QC tested).
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-1 beta, His Tag (Cat. No. ILB-H51H3) with an affinity constant of 0.571 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Muckle-Wells Syndrome (MWS); Cryopyrin-Associated Periodic Syndromes | Novartis Pharma Ag | 2009-06-17 | Gout; Dry Eye Syndromes; Arthritis, Gouty; Cryopyrin-Associated Periodic Syndromes; Wet Macular Degeneration; Sarcoidosis, Pulmonary; Cognitive Dysfunction; Alzheimer Disease; Primary Myelofibrosis; Cardiovascular Diseases; Muscular Dystrophy, Duchenne; Urticaria; Hyperimmunoglobulin D syndrome; Pulmonary Disease, Chronic Obstructive; Lung Neoplasms; Inflammation; Diabetes Mellitus; Carcinoma, Non-Small-Cell Lung; Anemia, Sickle Cell; Thrombocythemia, Essential; Diabetic Retinopathy; Peripheral Arterial Disease; Aortic Aneurysm, Abdominal; Behcet Syndrome; Pyoderma Gangrenosum; Hepatitis, Alcoholic; Diabetes Mellitus, Type 1; Prediabetic State; Familial Mediterranean Fever; Mevalonate Kinase Deficiency; Anemia; Atherosclerosis; Schnitzler Syndrome; Polycythemia Vera; Diabetes Mellitus, Type 2; Polyarticular Juvenile Idiopathic Arthritis; Still's Disease, Adult-Onset; Myelodysplastic Syndromes; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Vasculitis; Hereditary Autoinflammatory Diseases; Muckle- | Details |
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis, Knee; Osteoarthritis | Details |
Edaravone/(+)-2-Decanol | SIM-071201 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | 三贝心, 三贝欣, 先必新, Sanbexin | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Cerebral Hemorrhage; Stroke; Ischemic Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Cognition Disorders | Details |
Diacerein | KW-4800; SF-277; Art-50 | Approved | Cartivix, Fisiodar, Verboril, Art, 安必丁, Artrodar, Artrolyt | Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2; Coronavirus Disease 2019 (COVID-19); Insulin Resistance; Epidermolysis Bullosa; Osteoarthritis, Knee; Diabetes Complications; Osteoarthritis; Obesity; Osteoarthritis, Hip; Diabetes Mellitus; Overweight | Details | |||||
Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
Edaravone/(+)-2-Decanol (Yantai Yene/Simcere) | Y-2 | Approved | Yantai Yene Pharma Co Ltd, Simcere Pharmaceutical Group Ltd | Mainland China | Stroke | Jiangsu Simcere Pharmaceutical Co Ltd | 2024-12-01 | Intracranial Hemorrhages; Stroke; Cognitive Dysfunction | Details | |
Rilonacept | RGN-303; KPL-914 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst, 炎朵 | United States | Cryopyrin-Associated Periodic Syndromes | Kiniksa Pharmaceuticals Ltd | 2008-02-27 | Arthritis, Juvenile; Inflammation; Scleroderma, Diffuse; Renal Insufficiency, Chronic; Gout; Urticaria; Vascular Diseases; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Pericarditis; Diabetes Mellitus, Type 1; Coronary Artery Disease; Deficiency of interleukin-1 receptor antagonist; Scleroderma, Systemic; Muckle-Wells Syndrome (MWS); Sarcoidosis; Atherosclerosis; Schnitzler Syndrome; Anemia; Still's Disease, Adult-Onset; Familial Mediterranean Fever | Details |
Thalidomide | NSC-66847; NSC-527179; K-17; FPF-300; FPF300 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Mainland China | Leprosy, Lepromatous; Multiple Myeloma | Changzhou Pharmaceutical Factory | 1982-01-01 | Xerostomia; Colorectal Neoplasms; Neuroectodermal Tumors, Primitive; Prostatitis; Primary Myelofibrosis; Osteosarcoma; Cholangitis, Sclerosing; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Adenocarcinoma, Clear Cell; Carcinoma, Adenosquamous; Epilepsy; Erythema Nodosum; Sarcoma; HIV Wasting Syndrome; Pancreatitis, Chronic; Sarcoma, Ewing; Arachnoiditis; Gastrointestinal Hemorrhage; Retinoblastoma; Prostatic Neoplasms; Endometriosis; Lung Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Vascular Malformations; Myelodysplastic-Myeloproliferative Diseases; Mycobacterium avium-intracellulare Infection; Amyotrophic Lateral Sclerosis; Carcinoma, Hepatocellular; Burning Mouth Syndrome; Stomatitis; Neoplasm Metastasis; Appendiceal Neoplasms; Tuberculosis; Lymphoma, Non-Hodgkin; Angiodysplasia; Pelvic Pain; Glioma; Waldenstrom Macroglobulinemia; Leprosy, Lepromatous; Endometrial Neoplasms; Uterine Neoplasms; Anemia, Sideroblastic; Ovarian Neoplasms; Gastric Antral Vascular Ectasia; Lupus Erythematosus, Discoid; Carc | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Tissue Adhesions; Post-surgical adhesions; Cicatrix | Details |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | HIV Infections; Hematopoietic stem cell transplantation (HSCT); Solid tumours; Leukemia; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Dyslipidemias; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Melanoma | Details |
Lutikizumab | ABT-981 | Phase 3 Clinical | Abbvie Inc | Colitis, Ulcerative; Osteoarthritis, Knee; Hidradenitis Suppurativa; Osteoarthritis; Crohn Disease; Dermatitis, Atopic | Details |
Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Familial Mediterranean Fever; Still's Disease, Adult-Onset; Schnitzler Syndrome; ST Elevation Myocardial Infarction; Pancreatitis; Coronavirus Disease 2019 (COVID-19); Pericarditis; Arthritis, Gouty; Gout | Details |
Canakinumab biosimilar (GENERIUM Pharmaceuticals) | GNR-086 | Phase 3 Clinical | Generium Pharmaceuticals | Still's Disease, Adult-Onset; Arthritis, Juvenile | Details |
Recombinant humanized monoclonal antibody antiIL-1β(Cp Guojian) | SSGJ-613 | Phase 3 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Tumor necrosis factor receptor associated periodic syndrome; Arthritis, Juvenile; Arthritis, Gouty; Gout; Inflammation | Details |
MAS-825 | MAS-825; MAS825 | Phase 3 Clinical | Novartis Pharmaceuticals Corp | Enterocolitis; Coronavirus Disease 2019 (COVID-19); Coronary Disease; Autoimmune Lymphoproliferative Syndrome | Details |
AVTX-009 | FL-101; AVTX-009; LY-2189102 | Phase 2 Clinical | Eli Lilly And Company | Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Autoimmune Diseases; Urinary Bladder Neoplasms; Hidradenitis Suppurativa; Carcinoma, Non-Small-Cell Lung | Details |
CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Myocardial Infarction; Neoplasms; Lung Diseases; Stroke; Diabetic macular oedema; Colitis, Ulcerative; Crohn Disease; Macular Degeneration; Angioedemas, Hereditary; Diabetic Retinopathy | Details |
IL1-beta receptor antagonist Therapy(Hamlet BioPharma) | Phase 2 Clinical | Hamlet BioPharma AB | Cystitis; Pain | Details | |
Diacerein (TWi Biotechnology/Castle Creek Pharmaceuticals) | AC-201; AC-201 Controlled release tablet; AC-201 CR; AC-203; CCP 020; CCP-020 | Phase 2 Clinical | Twi Biotechnology Inc | Diabetes Mellitus, Type 2; Epidermolysis Bullosa Simplex; Epidermolysis Bullosa; Pemphigoid, Bullous; Epidermolysis Bullosa, Junctional; Gout; Arthritis; Epidermolysis Bullosa Dystrophica | Details |
Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087; XMA-0052 | Phase 1 Clinical | Xoma Corp | Colonic Neoplasms; Behcet Syndrome; Labyrinth Diseases; Panuveitis; Osteoarthritis; Uveitis; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Arthritis, Rheumatoid; Acne Vulgaris; Hereditary Autoinflammatory Diseases; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Pyoderma Gangrenosum; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 | Details |
DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
Tavo-103 | Tavo103; Tavo-103; TAVO-103A; TAVO103A | Phase 1 Clinical | Tavotek Biotherapeutics (Hong Kong) Ltd | Details |
This web search service is supported by Google Inc.